<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04035317</url>
  </required_header>
  <id_info>
    <org_study_id>CastanhaFontan</org_study_id>
    <nct_id>NCT04035317</nct_id>
  </id_info>
  <brief_title>Aesculus Hippocastanum L. on Fontan Circulation</brief_title>
  <official_title>Effect of Aesculus Hippocastanum L. (Sapindaceae, &quot;Horse Chestnut&quot;) on Fontan Circulation - a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Casa Espirita Terra de Ismael</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital das Clinicas de Ribeirao Preto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Casa Espirita Terra de Ismael</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients after the Fontan operation at a single institution will be randomized to receive a
      standardized extract of Aesculus hippocastanum L. (horse chestnut) or placebo for 4 months in
      a crossover clinical trial. The primary outcome will be the mesenteric artery resistance
      measured by Dopple sonography.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 31, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to receive Aesculus hippocastanum or placebo for 4 months, followed by 4 weeks of washout and crossover.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>The capsules will be identical in appearance and will be labelled only with patient's name.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mesenteric artery resistance</measure>
    <time_frame>After 4 months</time_frame>
    <description>Mesenteric artery resistance, measured by pulsed-wave Doppler, in 0.1 units</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Univentricular Heart</condition>
  <arm_group>
    <arm_group_label>Aesculus hippocastanum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive extract of Aesculus hippocastanum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aesculus Hippocastanum / Horse Chestnut</intervention_name>
    <description>Treatment for 4 months, washout of 4 weeks, then crossover for another 4 months.</description>
    <arm_group_label>Aesculus hippocastanum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Treatment for 4 months, washout of 4 weeks, then crossover for another 4 months.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Underwent Fontan surgery

        Exclusion Criteria:

          -  Severe adverse reaction

          -  Personal or parental request
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto</name>
      <address>
        <city>Ribeirão Preto</city>
        <state>Sao Paulo</state>
        <zip>14048-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarcisio J Silva Jr., MD</last_name>
      <phone>+5516-98184-2222‬</phone>
      <email>tjsj_7@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Paulo H Manso, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 23, 2019</study_first_submitted>
  <study_first_submitted_qc>July 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2019</study_first_posted>
  <last_update_submitted>July 25, 2019</last_update_submitted>
  <last_update_submitted_qc>July 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Casa Espirita Terra de Ismael</investigator_affiliation>
    <investigator_full_name>Fabio Carmona</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Fontan operation</keyword>
  <keyword>Aesculus hippocastanum</keyword>
  <keyword>mesenteric artery resistance</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

